1
|
Brockway JP, Carruthers WB, Zapata M, Reiling RB. Automatic breast CAD results for seven categories of abnormalities. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.27_suppl.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5 Background: This prospective study was conducted to determine efficacy of preclinical use of automatic computer-aided cancer detection (CAD) system. Patients were women of high risk referred for MRI of breast with goals of assessing sensitivity/specificity of an automatic CAD platform which used kinetic and morphological (spiculation, volume, solidity, surface area, elongation, maximum extent) tools. We assessed classification of abnormality using histopathology as our gold standard. Methods: 1,976 patients with 2,149 abnormalities included were scanned from 2007 to 2010. Patient inclusion criteria were women: with dense breasts; BRCA1 or BRCA2 genes; family history of cancer; suspected of having recurrent cancer; anomalous mammogram/ultrasound; pain; or clinical suspicion. All patients included gave institutionally IRB approved HIPAA compliant informed consent. CAD software post-processing was automatically applied to dynamic contrast-enhanced MRI (DCE-MRI). One pre- and 4 post-scan series were used to calculate wash-in/out parameters. System's automatic detection was applied to entire breast(s) volume. No manually placed regions of interest were used. Results: Of 1,976 women scanned, 361 had mastectomies, 17 had bilateral mastectomies, 488 had lumpectomies/excisional biopsies, 623 had core biopsies, 166 had non-surgical approaches; radiation or chemotherapy. Mean tumor resected was 2.95 cm; SD=2.88 cm, while CAD detected breast tumor calculated size was 3.20 cm; SD=2.66 cm. Conclusions: Automatic CAD applied to breast DCE-MRI demonstrated high sensitivity, reasonable specificity, and accurate estimates for location within breast, and volume of malignancy. Automatic 3D CAD translucent display will aid oncology planners in tumor localization, volume and extent estimations. [Table: see text]
Collapse
Affiliation(s)
- J. P. Brockway
- Presbyterian Cancer Center, Charlotte, NC; 361 Systems, Inc., Davidson, NC
| | - W. B. Carruthers
- Presbyterian Cancer Center, Charlotte, NC; 361 Systems, Inc., Davidson, NC
| | - M. Zapata
- Presbyterian Cancer Center, Charlotte, NC; 361 Systems, Inc., Davidson, NC
| | - R. B. Reiling
- Presbyterian Cancer Center, Charlotte, NC; 361 Systems, Inc., Davidson, NC
| |
Collapse
|
2
|
Reiling RB, Natale R, Wade J, Herbst R, Hensing T, Belani CP, Kelly K, Ochs J, Govindan R, Wozniak A, Krebs A. Efficacy and safety of gefitinib in chemo-naive patients with non-small cell lung cancer (NSCLC) in an expanded access program (EAP). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- R. B. Reiling
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - R. Natale
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - J. Wade
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - R. Herbst
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - T. Hensing
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - C. P. Belani
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - K. Kelly
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - J. Ochs
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - R. Govindan
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - A. Wozniak
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| | - A. Krebs
- Presbyterian Cancer Ctr, Charlotte, NC; Cedars-Sinai Cancer Ctr, Los Angeles, CA; Cancer Care Specialists of Central Illinois, Decatur, IL; M.D. Anderson Cancer Ctr, Houston, TX; Evanston Northwestern Healthcare, Evanston, IL; Univ of Pittsburgh, Pittsburgh, PA; Univ of Colorado Health Sciences Ctr, Aurora, CO; AstraZeneca Pharmaceuticals, Wilmington, DE; Washington Univ Sch of Medicine, St Louis, MO; Karmanos Ctr Institute/Wayne State Univ, Detroit, MI
| |
Collapse
|
3
|
Zinner R, Govindan R, Wozniak AJ, Wade JL, Belani CP, Thienelt CD, Hensing TA, Reiling RB, Natale RB, Wiznitzer I. Compassionate use experience with gefitinib in poor performance (PS) patients with advanced non-small-cell lung cancer (NSCLC) treated in an expanded access program (EAP). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- R. Zinner
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - R. Govindan
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - A. J. Wozniak
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - J. L. Wade
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - C. P. Belani
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - C. D. Thienelt
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - T. A. Hensing
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - R. B. Reiling
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - R. B. Natale
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| | - I. Wiznitzer
- UT M.D. Anderson Cancer Center, Houston, TX; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Center, Detroit, MI; Decatur Memorial Hospital, Decatur, IL; UPMC Cancer Pavilion, Pittsburgh, PA; Univeristy of Colorado Health Sciences Center, Denver, CO; Evanston Northwestern Healthcare, Evanston, IL; Presbyterian Cancer Center, Charlotte, NC; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Lynn Regional Cancer Center West, Boca Raton, FL
| |
Collapse
|
4
|
Reiling RB, Wade JL, Govindan R, Wozniak AJ, Hensing TA, Koshy S, Thienelt CD, Natale RB, Belani CP. Clinical benefit with compassionate use gefitinib in a subset of non-small-cell lung cancer (NSCLC) patients with the bronchoalveolar (BAC) subtype treated during an expanded access program (EAP). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- R. B. Reiling
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - J. L. Wade
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - R. Govindan
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - A. J. Wozniak
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - T. A. Hensing
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - S. Koshy
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - C. D. Thienelt
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - R. B. Natale
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| | - C. P. Belani
- Presbyterian Cancer Center, Charlotte, NC; Decatur Memorial Hospital, Decatur, IL; Washington University School of Medicine, St Louis, MO; Karmanos Cancer Institute, Detroit, MI; Evanston Northwestern Healthcare, Evanston, IL; UT M.D. Anderson Cancer Center, Houston, TX; University of Colorado Health Sciences Center, Denver, CO; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; UPMC Cancer Pavilion, Pittsburgh, PA
| |
Collapse
|
5
|
Abstract
A Forum for Our Readers Forum provides an opportunity for our readers to comment on the articles that we publish. Illustrative figures are welcome. Address correspondence to Forum, THE PHYSICIAN AND SPORTSMEDICINE, 4530 W 77th St, Minneapolls, MN 55435.
Collapse
|
6
|
Reiling RB. Perioperative red cell transfusion. Ohio Med 1990; 86:191-2. [PMID: 2333195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
7
|
Reiling RB. An American College of Surgeons response to the ODHS survey. Ohio Med 1988; 84:576-8. [PMID: 3047617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
8
|
Abstract
Although gastrointestinal staplers have a definite place in surgery because they are safe and effective, their distinct advantages are not clear cut. Surgeons in training should be accomplished in conventional suturing techniques before learning stapler techniques for similar anastomoses.
Collapse
|
9
|
Abstract
A controlled prospective study was carried out in a university-affiliated community hospital to evaluate the use of gastrointestinal staples compared with conventional sutures for anastomotic construction. The study included 100 randomized cases (50 sutured and 50 stapled) requiring anastomoses. Consecutive patients were accepted into the study, and no patients were excluded. There was no significant difference between the two groups in operating room time or the duration of postoperative hospitalization, nasogastric intubation or intravenous intubation. The complication rate was similar and comparable to previously published results. On three occasions, it was necessary during operation to convert from the use of staples to sutures when immediate disruption was noted at a gastroduodenal anastomosis.
Collapse
|